Completed PHASE3 INTERVENTIONAL 1-arm NCT01304394

Safety During Use of Paediatric Triple Chamber Bag Formulas

Safety During Use of Paediatric Triple Chamber Bag Formulas, Administered IV at a Weight Dependant Dose During 5 Consecutive Days, in Paediatric Patients up to 18 Years Requiring Parenteral Nutrition.

Sponsor: Baxter Healthcare Corporation

Conditions Digestive System Disorders Infant Nutrition Disorders Infant, Premature, Diseases

Interventions Ped3CB

Updated 6 times since 2017 Last updated: Feb 24, 2011 Started: Feb 29, 2008 Primary completion: Dec 31, 2008 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Digestive System Disorders and Infant Nutrition Disorders and is currently completed. Baxter Healthcare Corporation leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxter Healthcare Corporation

Data source: Baxter Healthcare Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bron, France , Liège, Belgium , Louvière, Belgium , Nancy, France , Nantes, France , Paris, France , Poitiers, France , Rennes, France , Rouen, France , Strasbourg, France and 1 more location